CiMaas BV
About CiMaas BV
The startup develops immunotherapy treatments that utilize patient-derived dendritic cells for a cancer vaccine and donor natural killer cells to enhance immune response against specific cancer types. This approach targets patients with cancers that are resistant to current therapies, minimizing severe side effects associated with traditional treatments.
What does CiMaas BV do?
The startup develops immunotherapy treatments that utilize patient-derived dendritic cells for a cancer vaccine and donor natural killer cells to enhance immune response against specific cancer types. This approach targets patients with cancers that are resistant to current therapies, minimizing severe side effects associated with traditional treatments.
Where is CiMaas BV located?
CiMaas BV is based in Maastricht, The Netherlands.
When was CiMaas BV founded?
CiMaas BV was founded in 2015.
How much funding has CiMaas BV raised?
CiMaas BV has raised 2930000.
- Location
- Maastricht, The Netherlands
- Founded
- 2015
- Funding
- 2930000
- Employees
- 2 employees